Stem cell technology company CellResearch Corporation has been a strategic partner of Cordlife Group since 2010.
Singapore-based healthcare company Cordlife Group has invested S$8.4m ($6m) in cord lining stem cell specialist CellResearch Corporation (CRC), also based in Singapore, as an extension of an existing strategic alliance.
Cordlife will supply half of the financing in the form of a three-year convertible note, while the remaining S$4.2m will structured as an equity investment.
The companies forged the partnership in 2010 to work on an umbilical cord lining banking service utilising CRC’s technology to harvest stem cells from the…
